Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Response to Exercise and Nitric Oxide in Peripheral Artery Disease: The RESIST PAD Trial

NCT06657976 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT06657976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06657976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Response to Exercise and Nitric Oxide in Peripheral Artery Disease: The RESIST PAD Trial
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Recruiting
Start date
January 23, 2025
Completion date
October 1, 2029
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

exercise, intermittent claudication, nitric oxide, peripheral artery disease